Literature DB >> 14741780

Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype.

Ghiabe H Guibinga1, Frederick L Hall, Erlinda M Gordon, Erkki Ruoslahti, Theodore Friedmann.   

Abstract

The production of potentially targetable VSV-G-pseudotyped retrovirus vectors has been hampered by inadequate understanding of the structure-function relationships of the VSV-G protein. In these studies we demonstrate assembly and production of MLV-based and HIV-1-based vector particles using VSV-G proteins modified by the insertion of a peptide ligand into a site corresponding to amino acid position 24 of the native VSV-G molecule. The inserted ligand represents the decapeptide encoding the collagen-binding domain of von Willebrand factor. We have used deconvolution microscopy to demonstrate that the modified VSV-G molecules sequester in perinuclear structures and are unavailable for assembly of infectious virus particles at the cell surface under standard tissue culture conditions at 37 degrees C. In contrast, at a lower permissive temperature of 30 degrees C, the modified VSV-G protein traffics appropriately to the cell surface and participates in useful titers. Furthermore, VSV-G-pseudotyped MLV-based and HIV-1-based vectors displaying the collagen-binding domain demonstrate a statistically significant increased attachment to a collagen matrix as indicated by an ELISA-like cell binding assay and by a focus transduction assay.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741780     DOI: 10.1016/j.ymthe.2003.09.018

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  15 in total

1.  Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 2.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

Review 3.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

4.  Rapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell line.

Authors:  Yanhua Gao; Patricia Whitaker-Dowling; Simon C Watkins; Judith A Griffin; Ira Bergman
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease?

Authors:  Ghiabe-Henri Guibinga; Gorjan Hrustanovic; Kathryn Bouic; Hyder A Jinnah; Theodore Friedmann
Journal:  Hum Mol Genet       Date:  2011-10-31       Impact factor: 6.150

6.  Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.

Authors:  Esmeralda Alvarado-Facundo; Yamei Gao; Rosa María Ribas-Aparicio; Alicia Jiménez-Alberto; Carol D Weiss; Wei Wang
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

Review 7.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

Review 8.  Synthetic immunosurveillance systems: nanodevices to monitor physiological events.

Authors:  Yvon L Woappi; Rahul Jangiti; Om V Singh
Journal:  Biosens Bioelectron       Date:  2014-05-10       Impact factor: 10.618

9.  Deficiency of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) dysregulates neurogenesis.

Authors:  Ghiabe-Henri Guibinga; Stephen Hsu; Theodore Friedmann
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

10.  Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligands.

Authors:  Arun Ammayappan; Kah-Whye Peng; Stephen J Russell
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.